WASHINGTON — A blood-based screening test detected colorectal cancer with a sensitivity of 79.2% and a specificity of 91.5% among average-risk adults aged 45 to 85 years, according to research presented at Digestive Disease Week.
“Adherence to colon cancer screening tests is suboptimal with current options of stool-based tests and colonoscopy,” Aasma Shaukat, MD, MPH, director
Reality Check: Data on Blood-Based Colorectal Cancer Screening miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A next-generation multitarget stool DNA test for colorectal cancer screening had higher sensitivity but lower specificity than a currently available FIT, according to the large prospective BLUE-C study.
Unsatisfactory fecal immunochemical tests often stem from inadequate or old specimens, incomplete labeling, or broken/leaking containers, and they may leave many patients unscreened.
Iterative Health released research findings that demonstrated the effectiveness of AI for use in the treatment and management of inflammatory bowel disease and